| 前收市價 | 3.0200 |
| 開市 | 3.0200 |
| 買盤 | 2.7000 |
| 賣出價 | 5.5000 |
| 拍板 | 4.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 3.0200 - 3.0200 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 1 |
Insider MonkeyAclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23835, expectations were $-0.28. Aclaris Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
ZacksAclaris Therapeutics (ACRS) Reports Q1 Loss, Tops Revenue Estimates
Aclaris (ACRS) delivered earnings and revenue surprises of 14.29% and 20.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksAre Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
Here is how Aclaris Therapeutics (ACRS) and Aldeyra Therapeutics, Inc. (ALDX) have performed compared to their sector so far this year.
